Prognostic impact of additional mineralocorticoid receptor antagonists in octogenarian heart failure patients.

The results of this study suggest that additional MRA to GDMT at discharge is one of the therapeutic options for elderly HF patients with reduced LVEF. This finding is not well documented in previous clinical trials.